(+91) 996 000 0984
geneOmbio Technologies Pvt Ltd, Office No. 302, 3rd Floor, Lalani Quantum , Above Chellaram hospital, Patil Nagar, Bavdhan Pune 411021
Newsroom · Pune, IndiaGeneOmbio in the News:
20+ Years of Precision Genomics
from Pune
Coverage, commentary and industry recognition for geneOmbio Technologies,
from NABL-accredited Molecular Diagnostics and Contract Research Services for biopharma, food and agriculture to
India’s first nutrigenomics lab
from NABL-accredited Molecular Diagnostics and Contract Research Services for biopharma, food and agriculture to
India’s first nutrigenomics lab
20+
Years of experience
10
Publications
3
Global market reports
2014
The Economic Times
Featured · Company milestone
geneOmbio Technologies launches India's first nutrigenomics lab in Pune
The Economic Times reported the opening of geneOmbio's nutrigenomics laboratory in Pune, the first of its kind in India, bringing gene–diet interaction testing to clinicians and nutritionists in the country. The same molecular platform now underpins the company's Pharmacogenomics, Molecular Diagnostics and Contract Research Services.
Coverage index
In the news
Publications and Press Release
Express Pharma - 2025
India's biopharma industry charts the road from biosimilars to innovation
A look at how Indian biopharma is moving beyond biosimilars toward original biologics, and the characterisation, testing and compliance infrastructure that shift demands.
The Indian Express - 2022
Nutrigenomics: how your diet interacts with your genes
The Indian Express explains how genetic variants shape individual responses to food, and why gene-guided nutrition is gaining ground with Indian clinicians and nutritionists.
The Times of India · Chennai - 2016
Nutrigenetics: why your food should sync with your genes
The Times of India on nutrigenetics in Indian practice and how genotype-informed diet plans move nutrition away from one-size-fits-all advice.
Business Standard · IANS - 2015
More young Indians embracing gene testing for healthy ageing
An IANS health feature quotes Dr Amol Raut, Chief Consultant (R&D) at geneOmbio Technologies, on scanning genes linked to metabolic, lifestyle and congenital conditions, and on next-generation sequencing as the future of diagnostics.
The Times of India - 2016
Can we blindly trust weight-loss centres?
The Times of India questions generic weight-loss programmes and makes the case for evidence-based, genetically informed approaches to weight management.
Gulf News - 2018
More young Indians embracing gene testing for healthy ageing
Gulf News carries an IANS feature on the rise of gene testing in India, quoting geneOmbio’s Dr Amol Raut on personalised prevention and the role of next-generation sequencing.
Industry Report
GlobeNewswire · MarketsandMarkets - 2026
Molecular Diagnostics Market to grow from USD 19.48 billion in 2025 to USD 30.74 billion by 2030
MarketsandMarkets names geneOmbio Technologies in the competitive landscape of the global molecular diagnostics market, alongside Roche, Illumina, QIAGEN and Thermo Fisher Scientific.
PR Newswire · Technavio - 2022
Pharmacogenomics market size to grow by USD 2.50 billion
Technavio's Global Pharmacogenomics Market 2022–2026 report profiles geneOmbio Technologies among the major market participants, with a dedicated vendor analysis of its services.
EIN Presswire · Emergen Research - 2022
Pharmacogenomics market estimated to reach USD 11.97 billion by 2028
Emergen Research lists geneOmbio Technologies among the key participants in the global pharmacogenomics market, together with Abbott, Illumina, Roche and LabCorp.
For journalists
About geneOmbio Technologies
geneOmbio Technologies Pvt. Ltd. is a precision genomics company based in Bavdhan, Pune, with more than 20 years of service to the research, healthcare and life-science industries. The company provides NABL-accredited Contract Research Services, including Molecular Identification (MID), Cell Bank Characterisation and DNA Barcoding, alongside Pharmacogenomics, Molecular Diagnostics and Nutrigenomics testing.
Its in-house R&D unit is recognised by the Department of Scientific and Industrial Research (DSIR), Government of India. The laboratory has processed over 500,000 samples and its scientists have authored 40+ peer-reviewed publications in microbiology, molecular diagnostics, pharmacogenomics and nutrigenomics.
Credentials to cite
NABL · ISO/IEC 17025:2017
Contract Research Services (Testing) · TC-14703 · valid to 31 Mar 2030
NABL · ISO 15189:2022
Molecular Diagnostics (Medical Testing) · MC-7038 · valid to 17 Dec 2028
DSIR-recognised in-house R&D unit
Ministry of Science & Technology, GoI · F. No. TU/IV-RD/2801/2025
Media enquiries
crs@geneombiotechnologies.com
+91 99600 00984
Secure your biological pipeline today.
Request a validated testing quote for Molecular Identification, Cell Bank Characterisation or
DNA Barcoding from our ISO/IEC 17025-accredited team in Pune.
DNA Barcoding from our ISO/IEC 17025-accredited team in Pune.
